Morningstar US Industrials (NASDAQ:MIST – Free Report) – Research analysts at HC Wainwright upped their FY2023 earnings per share estimates for shares of Morningstar US Industrials in a research note issued to investors on Tuesday, November 14th. HC Wainwright analyst P. Trucchio now forecasts that the company will post earnings of ($1.37) per share for the year, up from their prior estimate of ($1.39). HC Wainwright currently has a “Buy” rating and a $25.00 target price on the stock. The consensus estimate for Morningstar US Industrials’ current full-year earnings is ($1.46) per share. HC Wainwright also issued estimates for Morningstar US Industrials’ Q4 2023 earnings at ($0.31) EPS, FY2024 earnings at ($1.30) EPS, FY2025 earnings at ($1.12) EPS, FY2026 earnings at $0.21 EPS and FY2027 earnings at $2.23 EPS.
Morningstar US Industrials Price Performance
MIST opened at $2.23 on Friday. The stock’s 50 day moving average price is $2.83 and its 200-day moving average price is $3.22. Morningstar US Industrials has a 52-week low of $2.18 and a 52-week high of $5.20. The company has a debt-to-equity ratio of 1.72, a quick ratio of 13.89 and a current ratio of 10.45. The stock has a market capitalization of $74.66 million, a PE ratio of -1.62 and a beta of 1.82.
Hedge Funds Weigh In On Morningstar US Industrials
Institutional investors have recently bought and sold shares of the stock. Valeo Financial Advisors LLC boosted its position in shares of Morningstar US Industrials by 4.4% during the second quarter. Valeo Financial Advisors LLC now owns 118,699 shares of the company’s stock valued at $338,000 after purchasing an additional 5,000 shares in the last quarter. Alta Fundamental Advisers LLC increased its stake in shares of Morningstar US Industrials by 58.8% in the 1st quarter. Alta Fundamental Advisers LLC now owns 897,961 shares of the company’s stock worth $3,538,000 after acquiring an additional 332,500 shares in the last quarter. Affinity Asset Advisors LLC lifted its position in Morningstar US Industrials by 99.4% during the 1st quarter. Affinity Asset Advisors LLC now owns 199,382 shares of the company’s stock valued at $786,000 after acquiring an additional 99,382 shares during the period. Barclays PLC boosted its stake in Morningstar US Industrials by 32.0% during the first quarter. Barclays PLC now owns 846,828 shares of the company’s stock worth $3,336,000 after acquiring an additional 205,475 shares in the last quarter. Finally, Envestnet Asset Management Inc. purchased a new stake in Morningstar US Industrials in the fourth quarter worth about $56,000. 61.32% of the stock is owned by institutional investors.
Morningstar US Industrials Company Profile
Milestone Pharmaceuticals, Inc engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications.
- Five stocks we like better than Morningstar US Industrials
- EV Stocks and How to Profit from Them
- Williams-Sonoma is a steal for buy-and-hold investors
- How to Use High Beta Stocks to Maximize Your Investing Profits
- A closer look at Warren Buffett’s latest surprise purchase
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- GE stock surges to six-year high: What’s behind the move?
Receive News & Ratings for Morningstar US Industrials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morningstar US Industrials and related companies with MarketBeat.com's FREE daily email newsletter.